CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Posts Credit Financing Update

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, today announced that it is reviewing alternative financing options to complete construction at its facilities in Ancaster, Ontario and phase 1a at Valleyfield, Quebec. Per the update, TGODF’s previously disclosed discussions for ordinary course commercial bank facilities and equipment leasing are no longer available on the acceptable terms within the timeframes required due to changing market conditions. Presently, the company has no debt and $56.7 million in cash available in Canada, including $40.2 million in restricted cash allocated to capital expenditures. Construction at Ancaster is mostly complete with all grow rooms licensed by Health Canada and approximately six weeks left before substantial completion of the processing facility. The company anticipates submitting the evidence package for this final component to Health Canada for licensing by the end of November. TGODF plans to prioritize any financing secured to hasten commercial production in order to increase revenues. If it is unable to secure enough financing on reasonable terms, within the required timeframe, the company may modify the construction schedule for its Ancaster and Valleyfield projects.

To view the full press release, visit http://cnw.fm/E3GDq

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium, global, organic-cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic-hemp, CBD-oil operations in Canada and, through its wholly owned subsidiary HemPoland, distributes premium-hemp CBD oil in the EU. The company grows high-quality, certified-organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,000 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGOD

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Nearly a Thousand Businesses Sign Letter Asking Congress to Deschedule Marijuana

To mitigate the risks linked with vaping products purchased from the illicit markets, hundreds of leaders in the cannabis industry have signed a the letter for the descheduling of marijuana by Congress.

The letter is to be delivered on Thursday to the House and Senate leadership. The letter argues that the recent increases in injuries and deaths related to vaping are because there are no federal regulations on the sale and use of marijuana because marijuana remains to be a federally controlled substance. The injuries and death are a result of people using adulterated and unregulated weed.

The letter states that any death due to marijuana is one too many in the legal state-regulated marijuana industry. Therefore, to curb the illicit market and prevent future risks, the cannabis industry has to employ tools such as uniformity and good manufacturing practices.

The government should provide consumers with accurate and actionable information on the status of the illegal, untested, and dangerous marijuana products in the markets argued NCIA and its co-signers, who include companies such as Weedmaps, Berkeley Patients Group, SPARC, Leafly, and Vicente Sederberg LLP.

In an interview with a media outlet, the NCIA executive director, Aaron Smith, said that the members of Congress should understand that the failed prohibition policies permitting the continued operation of the unregulated underground market is the leading cause of the increase in the outbreak of vaping related illnesses.

He further stated that the regulation of alcohol at the federal and state level is the reason why there are no alcohol-related illnesses. Therefore, to improve state regulatory systems regarding marijuana and allow for comprehensive research on marijuana as well as limit the illicit market, it is essential for Congress to deschedule and regulate marijuana effectively.

To ensure that the citizens are not exposed to dangerous and untested marijuana products, the letter recommends the adoption of five policies.

First, the removal of cannabis from the Controlled Substances Act and start regulating marijuana in a sensible manner similar to that of alcohol. Moreover, make funds available for investigation of the illnesses by medical specialists in the state.

Secondly, to stop production of vaping equipment installed with thickening agents. The manufacturers should issue a recall of any vaping product that has Vitamin E acetate. Furthermore, licensed retailers should countercheck their stock to make sure they have no products containing Vitamin E acetate.

Thirdly, cannabis consumers should stop using vape cartridges obtained from illegal markets and cease future purchases of any vaping cartridges or products.

NCIA said that the other problem facing the industry is the federal regulations that prohibit legal marijuana businesses from forcing black market operators out of business. NCIA also added that the illicit activities would be disrupted and most probably removed from the markets by legitimate weed businesses if marijuana was removed from Controlled Substances Act.

According to Smith, the NCIA is ready to help the lawmakers and regulators ensure the safety of marijuana consumers. Industry analysts are of the view that companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTCQB: MCOA) long for the day when the federal government finally acts on all the calls that have been made to reschedule marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Study Finds Youth Cannabis Use Reduced After Marijuana Legalization in Washington

A new study by Washington State found that the number of youths using marijuana has reduced following the state legalization of recreational marijuana.

According to the study, the number of students in grades six, eight, 10, and 12 in King County purchasing marijuana for personal use reduced or remained constant the whole of 2016. The consumption rate of the female students in grade 10 remained constant while that of the male students decreased. However, there was a spike up to four times the number of alcohol users among the users and non-users of cannabis.

The Centers for Disease Control and Prevention Morbidity and Mortality published the findings in their weekly report this Friday supporting past studies with similar results on the decline of marijuana use among the youths after legalization of recreational cannabis in Washington and other states in the U.S.

To assess the health risk behaviors of the youth, the department of health in Washington conducts a Washington State Health Survey among public school students in grades six, eight, 10, and 12 after every two years. While conducting their study, the researchers from Seattle and King County analyzed the data from 2004-2016 on substance abuse before making their conclusions.

The researchers established that there was a decline in the number of sixth-graders using marijuana in the past 30 days, while there was no change in the number of eighth-graders who used weed in those 30 days. The rate of the sophomores and seniors consuming cannabis increased in the year 2004-2012; however, the percentage decreased after marijuana was legalized for personal use in 2012. The findings from the survey contradict the opponents who thought that legalizing marijuana would pave the way for access to cannabis by teenagers.

From the analyzed data, they found that grade 10 students who admitted to using marijuana in the past month also used other substances such as alcohol, vape pens, and cigarettes. 67% used alcohol, 43% vape pens, and 24% cigarettes.

The reason why the rate of marijuana consumption among teens decreased is because of the reduction in the illicit supply of weed by introducing legal competitors in the markets. The youth may have also lost interest in the drug once it became legal. The government should also monitor other factors that prompt the use of marijuana, such as association with family and friends.

The decline or constant state of marijuana consumption was also evident in the state of Colorado and Oregon, who legalized recreational marijuana in 2013 and 2014, respectively.

Analysts agree that marijuana industry players like Neutra Corp. (OTCQB: NTRR) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) feel vindicated that research has shown that legalization of marijuana was never a ploy to get kids using marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Blissco Wellness Brand Receives Cannabis Oil Sales License

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its premium wellness brand and a multi-licensed processor and distributor, Blissco Cannabis Corp., has received Health Canada licensing approval for the sale of cannabis oils from its facility in Langley, British Columbia. According to the update, the license allows Blissco to sell full spectrum cannabidiol (“CBD”) oil products, and Supreme Cannabis expects that the facility’s capacity will reach annual production of over 7,000,000 tincture bottles by the end of calendar year 2019. “With the receipt of the License and expanded extraction capacity, Blissco will be positioned to address the growing unmet demand for high-quality CBD oil products across Canada,” Supreme Cannabis CEO Navdeep Dhaliwal said in the news release. “Blissco’s legacy of premium whole flower products established a brand that represents quality and authenticity to wellness consumers. For over a year, Blissco’s team developed advanced oil processing and formulation capabilities based on the same ethos. Consumers will soon be able to experience high-quality CBD oil products from a premium wellness brand they have come to trust. The team at Blissco has developed sophisticated expertise and diligently executed against ambitious business objectives, their hard work and vision has led to this significant milestone.”

To view the full press release, visit http://cnw.fm/FkgG0

About Supreme Cannabis

The Supreme Cannabis Company is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the company has emerged as one of the world’s fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products. Supreme Cannabis’ portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco Cannabis Corp., a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada. For more information, visit the company’s website at www.Supreme.ca.

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://cnw.fm/SPRWF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Provides R&D Program Update

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today provided an update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine consumer products using Lexaria’s patented DehydraTECH(TM) technology. According to the update, most of the investigation and work within the first phase of the project underway between Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE:MO) and Lexaria’s majority owned subsidiary Lexaria Nicotine LLC is either complete or significantly underway, with imminent commencement of one remaining aspect. Results have been positive to date and support successful completion of this first phase. “The program between Altria and Lexaria is progressing nicely and is enabling a clearer understanding of the potential of delivering nicotine through oral forms that avoid lung absorption,” Lexaria Bioscience and Lexaria Nicotine CEO Chris Bunka said in the news release. “Lexaria strongly believes that, given the choice, many of the world’s one billion smokers would elect to experience their nicotine in a manner that does not rely on either smoking or vaping, and Lexaria can help enable these alternatives.”

To view the full press releases, visit http://cnw.fm/ZLv7o

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Cancellation of PCCBD Investment

Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Monday announced termination of the proposed investment into The Physician’s Choice CBD (“PCCBD”) of Phoenix, Arizona, as previously disclosed in April 2019. “I am disappointed to report that after many months of meetings, discussions and attempts to manage an increasingly frustrating process, Chemistree has decided that the proposed $1 million investment into what we believed was a compelling and unique company, cannot be made,” Chemistree President Karl Kottmeier said in the news release. “While scientifically excellent, our due diligence identified significant issues with PCCBD management. We ultimately determined that we could not arrive at a go forward plan, nor a definitive agreement and accordingly the proposed arrangement has been terminated, with no funds having been forwarded.”

To view the full press release, visit http://cnw.fm/jH8b7

About Chemistree Technology Inc.

Chemistree Technology Inc. is an investment company dedicated to the U.S. cannabis sector, endeavoring to provide turn-key solutions for the regulated cannabis industry.  The company’s corporate strategy is to acquire and develop vertically integrated cannabis assets, leveraging management’s decades of expertise in the cannabis industry and corporate finance to own and operate licensed cultivation, processing, distribution and retail facilities. For more information, visit the company’s website at www.Chemistree.ca.

NOTE TO INVESTORS: The latest news and updates relating to CHMJF are available in the company’s newsroom at http://cnw.fm/CHM

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Receives Health Canada Approval for Facility Expansion

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has gained Health Canada approval for a significant expansion at its Mississauga, Ontario facility. TerrAscend anticipates that the approval will assist in the company’s goal to meet the growing consumer demand for premium cannabis products and brands expected to surge as the next wave of Canadian cannabis legalization. The approval almost triples TerrAscend’s licensed space to 51,800 square feet. The new space will be comprised of supplementary cultivation capacity, a commercial kitchen, formulation rooms and larger primary and secondary packaging capacity.

To view the full press release, visit http://cnw.fm/XOf4g

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

Californian Cannabis Industry Blazes Trail of Growth for US

CannabisNewsWire Editorial Coverage: California continues to be the leading center for the U.S. cannabis industry, with huge growth already taking place and plenty of potential for more.

Cannabis Strategic Ventures (OTCQB: NUGS) (NUGS Profile) is among the growing number of California cannabis companies boasting multiple cultivation, manufacturing and distribution licenses. Its wholly owned and operated flagship farm, NUGS FARM, recently completed its first harvest. Like Cannabis Strategic Ventures, Acreage Holdings Inc. (OTCQX: ACRGF) is invested up and down the supply chain, with new brands targeting markets in California and elsewhere. Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) recently announced expansion in Pennsylvania, catering to the state’s 180,000 registered cannabis users. Halo Labs Inc. (OTCQX: AGEEF) provides vital support services to the California market, using cutting-edge technology to extract active ingredients from cannabis. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) has financed a fresh wave of expansion through a sale-and-leaseback agreement on its existing cultivation properties.

  • California’s industry is expected to be worth $3.1 billion this year and could reach more than three times this size as it takes over from the illegal market.
  • Public companies are expanding thanks to support from the state and ancillary businesses.
  • Federal legislation keeps many of these companies from stock exchange listings, so they are traded as over-the-counter shares.
  • Cultivation operations provide the bedrock for their growth.

To view an infographic of this editorial, click here.

California Leads the Way for Cannabis Industry

As with many other significant economic and social changes, California is currently leading the way in the legal cannabis market. The first state to legalize medical cannabis has created a whole new sector of the legal economy and continues to set the standard that the rest of the market follows. The words cannabis and California go hand in hand.

The fall harvest is approaching, highlighting how much cannabis cultivation in California has thrived. Growing consumer demand in both the medical and recreational cannabis segments has led to constant growth for the industry. Consumers want more and better cannabis, and companies are moving to meet that demand. Cannabis investment is rising as companies realize the potential rewards of investing in cannabis.

Maturing Industry Makes More Cannabis Stocks Available

Investors both inside and outside California have been turning their attention to the state’s cannabis industry. These investors are flocking to pick up stocks in cannabis-related enterprises such as Cannabis Strategic Ventures (OTCQB: NUGS), a cannabis-related holding company that has recently made significant investments in the Californian cultivation market.

The early days of the cannabis industry were uncertain ones for investors. Though California had taken the bold step of legalizing the medical cannabis industry, the shape of that industry and the profitability of companies remained uncertain. Questions about how the federal government would respond, given that this state-level legislation was at odds with federal laws shaped by the war on drugs, contributed to that uncertainty. Further changes such as the legalization of cannabis in California for recreational purposes, which happened only three years ago, have meant ongoing uncertainty and adaptation.

In-state progress has made positioned companies such as Cannabis Strategic Ventures for success. The state has a fully regulated market, with licensing arrangements for the production, processing and sale of cannabis. Sophisticated infrastructure is emerging to nurture the industry, both in the government machinery that regulates it and in the businesses that provide materials and services.

The result is a growing number of public companies, some new and others well established. Investors have a range of options to choose from and greater confidence than ever before that their money is in safe hands.

California’s Billion-Dollar Cannabis Industry

The central driver for growth is the high demand for cannabis that exists in California. The state’s legal cannabis industry is expected to reach $3.1 billion in sales this year, according to a report from research firms Arcview Market Research and BDS Analytics. This expected demand has fueled spectacular growth in the number and scale of cultivation operations, as new ones enter the market every year. Cannabis Strategic Ventures’ NUGS FARM site made its first sales this September and is building toward its full operational capacity for the start of next year. Others are in similar positions, gearing up from first sales to big cultivation and sales operations.

These sales are likely to increase as more of the state’s shadow market in cannabis moves into the light. Illegal operations in California are estimated to be worth $8.7 billion this year. The state is working to eradicate these operations and create a safer, better-regulated market that will protect consumers, workers and well-run businesses.

Operations such as NUGS FARM are both a result of and a contribution to the erosion of the illegal market. As police crack down on illegal operations, customers move toward legal outlets to obtain their drugs. In addition, the existence of legal outlets is itself a draw away from the illegal sellers. By providing a safe, legal way for customers to obtain what they’re looking for, with more consistent results and value for money, enforcement agencies are eroding the illegal market’s customer base.

Investing in Cannabis Off the Exchanges

Despite this, many cannabis companies are unable to list their stocks on American exchanges. Instead, the likes of Cannabis Strategic Ventures are traded as over-the-counter stocks on OTC Markets.

The reason behind this is federal legislation. Though many states have changed their views, the United States government still treats cannabis as a Schedule One drug, legally regarded to be as dangerous as heroin or LSD, despite the overwhelming scientific evidence against this stance. This means that companies that directly cultivate and sell recreational cannabis are barred from listing on U.S. financial exchanges. Some ancillary and biotech companies have found a way around this and onto the exchanges, while others have been listed in Canada instead. But for many, over-the-counter sales between traders remain the way forward.

The Practicalities of Cannabis Cultivation

Despite the challenge this situation creates, there is no shortage of funding for cannabis growers. For the first time, investors are starting to learn what a cannabis cultivation project looks like.

Many of these operations are based on indoor growing, which allows for greater security and consistency of results. NUGS FARM is a 6.5-acre greenhouse operation, using specialized farming equipment to feed, water and monitor the plants. The farm has licenses to cultivate, manufacture and distribute cannabis, giving Cannabis Strategic Ventures the right to be involved in and provide quality control through the entire supply chain. NUGS can produce tens of thousands of pounds of cannabis annually, with the plants coming from the company’s own unique, high-quality flower strains. NUGS has started booking sales of this produce as it gears up to full capacity in early 2020.

This is the shape of the Californian cannabis industry — sophisticated, forward looking and constantly expanding. Challenges such as the illegal market and federal regulations are being overcome — or even turned to the industry’s advantage.

All In On Cannabis

Across the 33 states in which medical or recreational cannabis is now legal, companies are enjoying similar patterns of expansion.

Starting with its founder’s investment in a cannabis license in Maine eight years ago, Acreage Holdings Inc. (OTCQX: ACRGF) has since expanded to create a company operating in states across the United States. A team of experts with experience in everything from legislation to healthcare to cultivation, the company is invested all along the supply chain, from cultivation to manufacturing to dispensing to branding. Acreage Holdings recently rolled out a new set of products under its House of Brands strategy. California is among the target markets for these products, tapping into that large and growing customer base.

Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) is another multistate operator with cultivation centers in a number of states. The company is focused on the medical rather than the recreational sector of the market, focusing on the health benefits that cannabis can bring. Green Thumb Industries recently opened its seventh retail store in Pennsylvania, a sizeable market with 180,000 in-state registered medical cannabis patients. Such moves have led to a tripling in Green Thumb’s revenues in the second quarter of this year.

The industry isn’t just about cultivation and retail; there’s a large base of support services backing that. Among those companies is Halo Labs Inc. (OTCQX: AGEEF), which specializes in the extraction of active ingredients from cannabis. This extraction allows the chemicals to be used in products ranging from medicines to vaping liquid to food and drink. Halo’s leading-edge technology gives it an advantage in the extraction market, a fast-moving segment based on swiftly changing technology. Halo Labs was recently awarded two new licenses for operations in California, where it already has a 9,400-square-foot campus dedicated to the processing of cannabis products.

A vertically integrated company working across the United States, Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) is one of the leading multistate cannabis companies. Cresco deals with the whole supply chain of cannabis, including cultivation, processing, packaging, shipping and sales in its own dispensaries. The company recently made a sale-and-leaseback deal on two of its cultivation properties in Illinois to provide extra funds for expansion in the state. Like California, Illinois has plenty of room for expansion, and the industry there is expected to eventually reach $2 to $4 billion in value. The deal will position Cresco to make the most of that growth.

The cannabis industry is growing in many states, following the lead of California, where a powerful market is forging the way ahead for the rest of the country.

For more information on Cannabis Strategic Ventures, visit Cannabis Strategic Ventures Inc. (NUGS)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – 5 Things to Discuss about Medical Marijuana with Your Doctor

In the United States today, there are a total of 33 states that have legalized the use marijuana in a medical setting, and 11 states have given the go-ahead to use marijuana for recreational purposes. However, the physician assistant school has not included the education on the effects of cannabis, the natural cannabis-like molecules (endocannabinoids), and the way THC interacts with other medicines as part of their nursing syllabus.

According to Theresa Mallick, who practices at the division of pain medicine in Stanford Health Care, due to changes in laws where weed is concerned, more patients are bound to ask about the possibilities of using marijuana either medical or recreationally. So, to keep them safe as a doctor, it is your responsibility to equip them with information on the positive and negative effects of marijuana.

Through the American Association of Nurse Practitioners, Theresa Mallick recently taught a webinar about marijuana. According to Mallick, it is essential for doctors to go ahead and address the topics below with their patients.

  1. Voice Your Opinion About Marijuana Consumption

Honesty is crucial in getting your patient to open up. Moreover, they will be able to accept your advice on whether marijuana is a suitable form of treatment or not if you are truthful about what your thoughts on marijuana are.

  1. When Talking About Marijuana with Your Patients, Ask Them to Register for Medical Marijuana Cards

Advise the patient to apply for the medical marijuana card, which is easy to get in the states where medical marijuana is legal. With the medical card, you will be able to provide them with information on medial utility, safety, and its interaction with other drugs, treatment agreements, and aims of care.

  1. Give Them Tips For Buying Marijuana Safely

When buying cannabis, there is a probability of buying contaminated products; therefore, patients should be educated on how to purchase safe products. Educate them on how to read labels, the base of the product either weed or hemp, the source, and the manufacturing process before the product reaches the market.

Also, advise them not to inhale any product containing propylene glycol since this could cause them respiratory problems.

  1. Help Them Distinguish Between Inhaled And Orally Ingested Marijuana

Mallick-Searle says that the probability of patients opting to use marijuana in edibles is high because many believe that it is safer than inhaling. However, she advises doctors to use the inhalation method when assessing patients as this will show how cannabis affects the patient’s blood levels and psycho-activity.  This is not possible with orally ingested marijuana as the time of cognitive effects varies.

  1. Inform Them About The Dangers Of Cognitive Impairment

Physicians have the responsibility of warning the patients on the dangers of conducting certain activities such as driving or operating machines while under the influence of weed. According to the Ontario Medical Association, the levels of THC in the ingested marijuana, and the mode of consumption determines the duration of the cognitive effect. When cannabis is inhaled, the impact takes place immediately and lasts only for a few hours, but when it is eaten in edibles, it takes a while for the effects to be apparent, and last longer than when inhaled.

Industry analysts are currently evaluating how marijuana companies like Hemptown USA and Sugarmade Inc. (OTCQB: SGMD) could be impacted by these findings.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Colorado Research Investigate Marijuana’s Ecological Footprint

The Department of Health and Environment in Denver, Colorado, is studying marijuana’s ecological footprint. Colorado Public Radio reported that researchers are conducting the studies not because the citizens of Colorado are releasing too much weed smoke into the air, but because they want to how the marijuana crop affects the environment.

An environment consultant with CPDHE, Katilin Urso, said that Colorado is not adhering to the ozone standards set by the Environmental Protection Agency. Ozone is a type of gas made of oxygen atoms, and it is hazardous in the atmosphere. In Colorado, ozone gas is rated as the highest pollutant, and this prompted the researchers to probe into what is contributing to excess emission of the ozone gas.

When Kyle Clark spoke to Urso, she said that the reason why the researchers are looking at the marijuana plant is that it produces terpenes (volatile organic compounds), which give the plant its unique scent.

When terpenes mix with other air pollutants and the sun, they add to the dangerous ozone layers which can make the air unfit for people to breathe.

According to Urso, the question most researchers are attempting to answer is the extent to which the marijuana sector is adding to the increases in the damage to the ozone layer. Moreover, how much terpenes are released into the atmosphere for each pound of marijuana grown? Also, they want to identify ways to develop environmental-friendly practices to be adopted by the marijuana industry.

Urso said the reason they are studying marijuana is that it is one of the many plants that emit volatile organic compounds in the environment. They are studying cannabis because of zoning and regulations, citing that the Denver metro area has the highest level of pollution and population, and is also where most marijuana legal growers are located. The marijuana industry and the growers are cooperating with the state in terms of data collection.

The Department of Health in Colorado’s primary purpose of this study is to determine the specific components being released into the air by the marijuana plant. This is because the Environmental Protection Agency (EPA) failed to quantify the effect of marijuana on the environment in the legalized states.

Morgan Fox says that he has been aware of the research which started in 2018 and is to end in September 2019 with the findings being released the coming summer. He says that he supports the study, although he does not know precisely how marijuana is contributing to the ozone depletion problem. To contribute positively to the environment, as an industry, they have adopted better lighting and planting techniques. They have also introduced a recycling system where customers can recycle the packaging through proper sanitization.

In 2011, the Department of Health conducted similar research on beer craft industries. Although they were causing much damage to the environment, the department suggested more efficient ways such as recycling bags used in production. They also warned against spilling beer during packaging because it releases ethanol upon evaporation, which is bad for the environment.

Analysts expect industry players like Earth Science Tech Inc. (OTCQB: ETST) and Geyser Brands Inc. (TSX.V: GYSR) to eagerly await the findings of this research since more light would be shed on an aspect of the marijuana industry that hadn’t been scientifically investigated.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com